Jiangsu Hengrui Jumps 25% in Solid Hong Kong Trading Debut

Chinese Firms’ Stellar HK Debuts Spur Hopes of Valuation Shift

The robust performance of two major Hong Kong stock listings this week has raised hopes that a small group of elite Chinese companies may start driving a shift to end the city’s historical discount to mainland markets.

Jiangsu Hengrui jumps 25% in solid Hong Kong trading debut

Company raises HK$9.89 billion (US$1.29 billion), with the proceeds to be used to support clinical trials and expand production capacity.

Chinese pharma firm debut adds to hope for Hong Kong listing fortunes

Chinese pharmaceutical firm Jiangsu Hengrui had a storming first day of trading in Hong Kong on Friday, up 25.2 percent at closing — a sign of hope for the city’s prospects as a listing hub. Hong Kong saw a steady decline in new offerings after a regulatory crackdown by Beijing in 2020 led some mainland Chinese mega-companies to put their plans on hold. A  national security law imposed on the semi-autonomous city the same year added to the uncer…

Chinese Drugmaker’s Shares Jump in Strong Hong Kong Debut

Shares of Jiangsu Hengrui Pharmaceuticals soared Friday morning, as more companies seek to tap Hong Kong’s capital markets.

Hengrui Pharma Raises $1.3 Billion in Hong Kong IPO - Blockchain & Cryptocurrencies Tabloid

Hengrui Pharmaceuticals debuts on Hong Kong Exchange, raising $1.3 billion amid high demand. The post Hengrui Pharma Raises $1.3 Billion in Hong Kong IPO appeared first on Blockchain & Cryptocurrencies Tabloid.

Hengrui Pharmaceuticals Soars 25% on Trading Debut After Biggest Hong Kong Pharma IPO in Five Years - YT FINANCE

The post Hengrui Pharmaceuticals Soars 25% on Trading Debut After Biggest Hong Kong Pharma IPO in Five Years appeared first on YT FINANCE.